Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohort

Lodewijk R. J. de Ruiter(Leiden University), Bernard M.J. Uitdehaag(Amsterdam UMC Location Vrije Universiteit Amsterdam), Eline M. E. Coerver(Amsterdam Neuroscience), Eva Strijbis(Amsterdam University Medical Centers), Floor C. Loonstra(Leiden University), Ilona C.E. van Leeuwen(Amsterdam Neuroscience), Samantha Noteboom(Université de Bordeaux), Bastiaan Moraal(Amsterdam UMC Location Vrije Universiteit Amsterdam), Menno M. Schoonheim(Amsterdam Neuroscience), Julia R. Jelgerhuis(Amsterdam Neuroscience), Alyssa A Toorop(Amsterdam Neuroscience)
Multiple Sclerosis and Related Disorders
February 12, 2023
10.1016/j.msard.2023.104568
Cited by 11

Related Papers

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
|Multiple Sclerosis Journal|2020|2.5k
Loss of ‘Small-World’ Networks in Alzheimer's Disease: Graph Analysis of fMRI Resting-State Functional Connectivity
|PLoS ONE|2010|621
Intracortical Lesions in Multiple Sclerosis: Improved Detection with 3D Double Inversion-Recovery MR Imaging
|Radiology|2005|509
Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
|The Lancet Neurology|2008|484